$3 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 120 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 50.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON PHARMA PLC | $425,908,000 | +28.2% | 12,259,875 | -4.2% | 14.19% | +31.9% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $68,707,000 | -21.2% | 9,529,361 | -19.5% | 2.29% | -19.0% |
| BLUE | Sell | BLUEBIRD BIO INC | $55,020,000 | -27.8% | 326,783 | -48.2% | 1.83% | -25.8% |
| DVA | Sell | DAVITA HEALTHCARE PARTNERS I | $50,543,000 | -14.8% | 636,000 | -12.9% | 1.68% | -12.4% |
| UAM | Sell | UNIVERSAL AMERN CORP NEW | $44,626,000 | -19.4% | 4,409,703 | -15.0% | 1.49% | -17.1% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $44,462,000 | +34.1% | 361,953 | -0.5% | 1.48% | +37.9% |
| ZFGN | Sell | ZAFGEN INC | $34,894,000 | -16.1% | 1,007,614 | -4.1% | 1.16% | -13.7% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $32,404,000 | -19.7% | 6,983,710 | -24.3% | 1.08% | -17.3% |
| XNCR | Sell | XENCOR INC | $31,000,000 | +6.7% | 1,411,000 | -25.6% | 1.03% | +9.8% |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $26,993,000 | -51.3% | 2,465,129 | -37.9% | 0.90% | -50.0% |
| LOXO | Sell | LOXO ONCOLOGY INC | $26,146,000 | +32.0% | 1,450,151 | -8.9% | 0.87% | +35.7% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $22,265,000 | -25.6% | 305,000 | -48.8% | 0.74% | -23.4% |
| INSM | Sell | INSMED INC | $21,772,000 | -35.7% | 891,546 | -45.3% | 0.72% | -33.9% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $19,008,000 | +27.7% | 1,232,696 | -15.6% | 0.63% | +31.3% |
| IMPR | Sell | IMPRIVATA INC | $15,675,000 | +9.2% | 958,152 | -6.6% | 0.52% | +12.3% |
| OFIX | Sell | ORTHOFIX INTL N V | $15,159,000 | -33.0% | 457,699 | -27.4% | 0.50% | -31.1% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $15,024,000 | -31.1% | 329,837 | -42.6% | 0.50% | -29.0% |
| HUM | Sell | HUMANA INC | $14,442,000 | -23.7% | 75,500 | -29.0% | 0.48% | -21.5% |
| TRUP | Sell | TRUPANION INC | $14,133,000 | -16.0% | 1,715,211 | -18.4% | 0.47% | -13.6% |
| AACH | Sell | AAC HLDGS INC | $13,200,000 | -3.3% | 303,027 | -32.1% | 0.44% | -0.5% |
| TNXP | Sell | TONIX PHARMACEUTICALS HLDG C | $11,800,000 | +36.8% | 1,315,551 | -3.6% | 0.39% | +40.9% |
| AXGN | Sell | AXOGEN INC | $11,701,000 | -13.6% | 3,726,439 | -3.7% | 0.39% | -11.2% |
| IMMU | Sell | IMMUNOMEDICS INC | $10,174,000 | +6.0% | 2,505,872 | -0.0% | 0.34% | +9.0% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $8,559,000 | -51.9% | 1,485,861 | -51.3% | 0.28% | -50.6% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $7,747,000 | -22.6% | 564,257 | -33.2% | 0.26% | -20.4% |
| ADHD | Sell | ALCOBRA LTD | $7,118,000 | -10.5% | 1,088,449 | -23.0% | 0.24% | -8.1% |
| DSCI | Sell | DERMA SCIENCES INC | $6,937,000 | -17.4% | 968,881 | -2.2% | 0.23% | -15.1% |
| ZSPH | Sell | ZS PHARMA INC | $6,915,000 | +11.5% | 132,000 | -10.4% | 0.23% | +14.4% |
| STDY | Sell | STEADYMED LTD | $6,744,000 | -37.4% | 1,267,577 | -0.0% | 0.22% | -35.5% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $4,773,000 | -31.5% | 160,259 | -46.2% | 0.16% | -29.6% |
| Sell | TRILLIUM THERAPEUTICS INC | $3,760,000 | -17.8% | 172,307 | -23.8% | 0.12% | -15.5% | |
| BVX | Sell | BOVIE MEDICAL CORP | $1,920,000 | +14.8% | 688,229 | -1.7% | 0.06% | +18.5% |
| CDNA | Sell | CAREDX INC | $1,489,000 | -66.6% | 229,000 | -71.5% | 0.05% | -65.3% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $369,000 | -89.4% | 20,859 | -89.6% | 0.01% | -89.3% |
| IMRSQ | Exit | IMRIS INC | $0 | – | -147,076 | -100.0% | -0.01% | – |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -143,200 | -100.0% | -0.01% | – |
| PTBIW | Exit | PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201 | $0 | – | -375,000 | -100.0% | -0.01% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -3,500 | -100.0% | -0.01% | – |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -29,900 | -100.0% | -0.02% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -45,600 | -100.0% | -0.02% | – |
| AEZS | Exit | AETERNA ZENTARIS INC | $0 | – | -898,574 | -100.0% | -0.02% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -13,000 | -100.0% | -0.02% | – |
| AGRX | Exit | AGILE THERAPEUTICS INC | $0 | – | -105,000 | -100.0% | -0.03% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -17,500 | -100.0% | -0.04% | – |
| PTBI | Exit | PLASMATECH BIOPHARMACEUTICAL | $0 | – | -349,908 | -100.0% | -0.04% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -6,400 | -100.0% | -0.04% | – |
| PARNF | Exit | PARNELL PHARMACEUT HLDGS LTD | $0 | – | -253,592 | -100.0% | -0.04% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -802,568 | -100.0% | -0.05% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -49,400 | -100.0% | -0.05% | – |
| IMMU | Exit | IMMUNOMEDICS INCcall | $0 | – | -500,000 | -100.0% | -0.06% | – |
| SCMP | Exit | SUCAMPO PHARMACEUTICALS INCcl a | $0 | – | -225,000 | -100.0% | -0.11% | – |
| Exit | EXELIXIS INCnote 4.250% 8/1 | $0 | – | -4,985,000 | -100.0% | -0.12% | – | |
| RTRX | Exit | RETROPHIN INC | $0 | – | -158,223 | -100.0% | -0.12% | – |
| CCRN | Exit | CROSS CTRY HEALTHCARE INC | $0 | – | -366,724 | -100.0% | -0.14% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -473,588 | -100.0% | -0.15% | – |
| LMNS | Exit | LUMENIS LTD | $0 | – | -434,566 | -100.0% | -0.17% | – |
| CLLS | Exit | CELLECTIS S Asponsored ads | $0 | – | -150,506 | -100.0% | -0.17% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -339,703 | -100.0% | -0.20% | – |
| KERX | Exit | KERYX BIOPHARMACEUTICALS INC | $0 | – | -765,450 | -100.0% | -0.32% | – |
| TRIV | Exit | TRIVASCULAR TECHNOLOGIES INC | $0 | – | -990,202 | -100.0% | -0.34% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -2,223,310 | -100.0% | -0.44% | – |
| OVAS | Exit | OVASCIENCE INC | $0 | – | -407,108 | -100.0% | -0.46% | – |
| GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -200,000 | -100.0% | -0.64% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -2,810,164 | -100.0% | -0.90% | – |
| Exit | INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1 | $0 | – | -47,428,000 | -100.0% | -1.77% | – | |
| Exit | HORIZON PHARMA INCnote 5.000%11/1 | $0 | – | -16,014,461 | -100.0% | -2.53% | – | |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES IN | $0 | – | -2,117,473 | -100.0% | -2.78% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -1,534,000 | -100.0% | -2.91% | – |
| ASPX | Exit | AUSPEX PHARMACEUTICALS INC | $0 | – | -4,449,103 | -100.0% | -14.45% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.